Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

0.6284
-0.0006-0.10%
Volume:455.27K
Turnover:281.35K
Market Cap:45.95M
PE:-2.65
High:0.6400
Open:0.6300
Low:0.6022
Close:0.6290
52wk High:1.40
52wk Low:0.5401
Shares:73.12M
Float Shares:45.25M
Volume Ratio:0.91
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2368
EPS(LYR):-0.2368
ROE:-188.78%
ROA:-71.29%
PB:5.08
PE(LYR):-2.65

Loading ...

BRIEF-Icecure Reports Financial & Operational Results For The Nine Months Ended September 30, 2025

Reuters
·
Nov 19, 2025

Icecure Medical Q3 EPS $0.06 Beats $(0.05) Estimate, Sales $850.000K Beat $714.000K Estimate

Benzinga
·
Nov 19, 2025

IceCure Medical reports nine-month financial results through September 2025

Reuters
·
Nov 19, 2025

IceCure Medical Wins FDA Approval for ProSense Cryoablation System for Low-Risk Breast Cancer

Reuters
·
Nov 19, 2025

Icecure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025

THOMSON REUTERS
·
Nov 19, 2025

Icecure Medical: Demand for Prosense Systems Expected to Accelerate in 2026

THOMSON REUTERS
·
Nov 19, 2025

BRIEF-Icecure's Prosense® Cryoablation System Receives Regulatory Approval In Switzerland For Indications Including Breast, Lung, Liver, And Kidney Cancer

Reuters
·
Nov 18, 2025

Icecure's Prosense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer

THOMSON REUTERS
·
Nov 18, 2025

IceCure Medical Receives Nasdaq Bid Price Notification

TIPRANKS
·
Nov 15, 2025

IceCure Medical receives noncompliance notification from Nasdaq

TIPRANKS
·
Nov 15, 2025

BRIEF-IceCure Medical Announces Receipt Of Nasdaq Minimum Bid Price Notification

Reuters
·
Nov 15, 2025

Icecure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

THOMSON REUTERS
·
Nov 15, 2025

IceCure Medical Ltd. to Report Third Quarter 2025 Results

Reuters
·
Nov 12, 2025

IceCure Medical Promotes Shay Levav to Chief Operating Officer

Reuters
·
Nov 10, 2025

Icecure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction

THOMSON REUTERS
·
Nov 10, 2025

IceCure Medical Showcases FDA-Authorized ProSense Device for Minimally Invasive Breast Cancer Treatment

Reuters
·
Nov 04, 2025

IceCure Cryoablation System Shows 74% Five-Year Survival in Stage I Lung Cancer Study

Reuters
·
Nov 03, 2025

Icecure Medical Ltd expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

IceCure Medical Announces Termination of VP of Operations and Services, Effective January 2026

Reuters
·
Oct 17, 2025

Investors push IceCure Medical (NASDAQ:ICCM) 13% lower this week, company's increasing losses might be to blame

Simply Wall St.
·
Oct 13, 2025